These observations suggest that Bach1 may serve as a unique strategy for patients with OSA-related lung cancer, but more work is needed to fully verify the role of Bach1 in OSA-deteriorated lung cancer. The gene discussed is BACH1; the disease is obstructive sleep apnea syndrome.